Aortic dissection (AD) is a devastating, heterogeneous condition of aorta. The homeostasis between collagens and matrix metalloproteases (MMPs)/tissue inhibitors of MMPs (TIMPs) system in the extracellular matrix plays an important role for structure and functions of aorta. However, our knowledge on association between variants of genes in this system and pathogenesis of AD is very limited. We analyzed all yet known coding human genes of collagens (45 genes), MMPs/TIMPs (27 genes) in 702 sporadic AD patients and in 163 matched healthy controls, by using massively targeted next-generation and Sanger sequencing. To define the pathogenesis of potential disease-causing candidate genes, we performed transcriptome sequencing and pedigree co-segregation analysis in some genes and generated Col5a2 knockout rats. We identified 257 pathogenic or likely pathogenic variants which involved 88.89% (64/72) genes in collagens-MMPs/TIMPs system and accounted for 31.05% (218/702) sporadic AD patients. In them, 84.86% patients (185/218) carried one variant, 12.84% two variants and 2.30% more than two variants. Importantly, we identified 52 novel probably pathogenic loss-of-function (LOF) variants (20 nonsense, 16 frameshift, 14 splice sites, one stop-loss, one initiation codon) in 11.06% (50/452) AD patients, which were absent in 163 controls (P=2.5×10 −5 ). Transcriptome sequencing revealed that identified variants induced dyshomeostasis in expression of collagens-TIMPs/MMPs systems. The Col5a2 −/− rats manifested growth retardation and aortic dysplasia. Our study provides a first comprehensive map of genetic alterations in collagens-MMPs/TIMPs system in sporadic AD patients and suggests that variants of these genes contribute largely to AD pathogenesis. aortic dissection, collagen, matrix metalloproteinase, next-generation sequencing, genetic diagnosis
INTRODUCTION
Aortic dissection (AD) is a disease of life-threatening emergency associated with high mortality and is difficult to be predicted (Gao et al., 2016; Nienaber and Eagle, 2003; *Corresponding author (email: dwwang@tjh.tjmu.edu.cn) **Corresponding author (email: david37212@hotmail.com) al., 2009). AD usually occurs in non-syndromic and sporadic form (~80%) or in association with hereditary genetic disorders, such as familial thoracic aortic dissection (fTAAD), Marfan syndrome (MFS), the vascular type of Ehlers-Danlos syndrome (EDS), Loeys-Dietz syndrome (LDS), and arterial tortuosity syndrome (ATS) (Goldfinger et al., 2014; Hoffjan, 2012; Khau Van Kien et al., 2004; Ritelli et al., 2009) . Although previous genetic studies in familial AD cases have identified several genes (Table S1 in Supporting Information) responsible for this disease, large fraction of clinical cases, especially sporadic cases, still lack genetic targets (Campens et al., 2015; Guo et al., 2011) .
Except for a genome-wide association study (GWAS), no previous studies have systematically investigated the genetic basis of sporadic spontaneous AD or the relationship between genotype and phenotype heterogeneity, especially for collagens and matrix metalloproteases (MMPs)/tissue inhibitors of MMPs (TIMPs) (LeMaire et al., 2011) . However, GWASs were performed using only known genetic markers involved in both cases and healthy controls, the ability to identify novel pathogenesis is limited compared with direct sequencing (Marian and Belmont, 2011; Salomon et al., 2016) . It is clear that the imbalance of the homeostasis between collagens and MMPs/TIMPs system is a key responsible for extracellular matrix (ECM) degeneration and structure and functions of aorta, and therefore may contribute to the pathogenesis of AD (Barbour et al., 2007; Theruvath et al., 2012; Tsamis et al., 2013) . However, to date, except for gene COL3A1, no pathogenic genes in collagens and MMP/TIMPs system have been demonstrated in AD patients (Sakai et al., 2012; Smith et al., 2011) .
To systematically study the pathogenic basis of genes in collagens and MMP/TIMPs system in sporadic AD, we sequenced all 72 related genes in the system in 702 patients with sporadic AD and in 163 matched healthy controls. According to the guideline (Richards et al., 2015) , we identified 257 pathogenic or likely pathogenic variants in 31.05% (218/702) patients, including 52 novel probably pathogenic loss-of-function (LOF) variants.
RESULTS

Targeted resequencing output and quality
We obtained sequence data for 2,496 amplicons of 2,279 exons from 72 targeted genes for 702 sporadic AD patients and 165 controls. On average, we gained 4,756,177 mapped reads per sample with a mean base coverage depth of 716-fold. In summary, 99.70% of the target amplicons were covered at least once, 98.62% were covered at least 20 times, and 96.06% were covered at least 100 times in coding regions.
Identification of pathogenic or likely pathogenic variants
Using stringent criteria (Richards et al., 2015) , in all we identified two pathogenic and 255 likely pathogenic variants in the 72 genes in 31.05% (218/702) of the AD patients, and most of these genes harbored more than one likely pathogenic mutation (Figure 1 and Table S2 in Supporting Information) .
Importantly, we identified 52 probably pathogenic LOF variants in collagens or MMPs/TIMPs genes in the 702 AD cases. We did not observe any pathogenic or probably path- ). These LOF variants include 20 nonsense, 16 frameshift, 14 splice-sites, one stop-loss, and one initiation-codon-break (Table 1 ). In addition, none of these LOF variants carriers had potential pathogenic variants in the 12 known AD pathogenic genes (Table S1 in Supporting Information).
Copy number variation (CNV) analysis
To evaluate the copy number across the targeted genes and to identify potential large heterozygous or homozygous deletion, the copy number of all sequenced regions of the 702 cases and 163 controls using Ion reporter 5.0. CNVs were analyzed and then further validated by real-time PCR. However, we did not find any large deletion in all participants.
Correlations between phenotype and genotype
It is clear that sporadic AD presents high genetic heterogeneity, as at least 64 genes are implied to responsible for its pathogenesis in our study. The genotype-phenotype relationship is complex in this disease. We firstly found genes that were previously thought to be associated with specific syndromes (COL4A3, COL4A4, COL4A5: Alport syndrome, COL6A3, COL6A6, COL6A5: Bethlem myopathy, COL18A1: Knobloch syndrome, COL14A1: punctate palmoplantar keratoderma, MMP19: Cavitary optic disc anomalies, and COL7A1: Epidermolysis bullosa dystrophica) (Theocharis et al., 2016 ) also contribute to non-syndromic sporadic AD pathogenesis. We did not identify related symptoms in our AD patients after carefully examination. Furthermore, the same pathogenic or likely pathogenic variants were never shared by more than four patients in our study, and most of the variants were unique 
102584189C>T Novel a) *, indicates count of the variants in AD patients; **, CM122891 is the pathogenic number in HGMD database. Li, Z., et al. Sci China Life Sci January (2017) Vol. 60 No. 1 to single patient. These results indicate that there is no "hotspot" in this disease. In all explained cases, 12.84% (28/218) harbored two variants, 1.83% (4/218) harbored three variants and one harbored four variants. We investigated the patients who had multiple variants and found that they suffered from AD in earlier onset age (Figure 2A ), and lower percentage of DeBaKey Type 3 AD (mild type of AD) ( Figure 2B ).
To evaluate the effect of these AD-associated genes in different systems, we compared the average AD onset age between collagens and MMPs/TIMPs genes ( Figure 2C ), as well as percentage of DeBaKey Type 3 AD ( Figure 2D ). Results showed that there is no significant difference of AD onset age or severity between collagens and MMPs/TIMPs genes. However, if patients carried them in both systems, they were observed to suffer from worse prognosis ( Figure  2C and D).
Pedigree co-segregation analysis
We performed pedigree co-segregation analysis of a 45-yeayold-onset AD patient (AD337, II-1), who carried only a nonsense variant of COL14A1 ( Figure 3A) . The father (I-1) died because of AD at the same age of the proband. The proband and his son (III-1), 20-year-old, carried the same variant in COL14A1 (p.Arg1473Ter). All other their relatives are of wild type. Maybe his son is too young to develop AD. All pathogenic and likely pathogenic variants we identified in sporadic AD cases are heterozygous, implying that there might be de novo variants. In order to validate this assumption, we sequenced all healthy relatives of AD patient AD606 with a COL6A5 frameshift variant, and the results supported our hypothesis ( Figure 3B ).
Col5a2 knockout rats display thoracic aortic dysplasia
To evaluate the pathogenesis of COL5A2 gene defect in AD, we generated four Col5a2 knockout rats (Col5a2 −/− ) by inducing a large deletion containing the exon 1 of Col5a2. The four Col5a2 −/− rats showed growth retardation. Histological analysis revealed thoracic aortic dysplasia at nine weeks. In the lesion region, the media was demonstrated loss of smooth muscle cells. The elastin fibers were loss, disarray and fragmentation in the same region. In the rest part of the loose hyperplasia media there was increased collagen deposition versus control. The adventitia is loose from the media and showed hyperplasia (Figure 4) . These changes are similar to pathology of human aorta dissection.
The mRNA-expression analysis
Firstly, we detected all selected genes except for MMP7 by transcriptome sequencing in healthy control aortas. Analysis of mRNA-expression revealed that TIMP1, COL6A2, COL1A1, COL1A2, TIMP3, COL3A1, COL4A2 and COL4A1 were most aorta-enriched in healthy control aortas ( Figure S1 in Supporting Information).
By mRNA-expression analysis, we found that seven of nine variants (one LOF variant and eight missense variants) result in significant downregulation of their corresponding mRNA in aorta wall of AD patients while one splice variant and other two missense variants result in significant upregulation of their mRNAs ( Figure S2A and B in Supporting Information). Interestingly, these three upregulated genes are all most enriched genes in normal aorta, which indicate that the upregulation of these genes may largely affect the ECM structure of aorta wall.
We investigated the expressed mRNA profiles of one patient who carried FBN1 frameshift pathogenic variant and six patients who carried collagens or MMPs/TIMPs likely pathogenic variants compared with healthy controls. Importantly, we found that TIMP3 and TIMP1 were downregulated in FBN1-affected AD profile, but TIMP1 was significantly unregulated in collagen-related AD profiles. This indicates that the pathogenic mechanism of collagen-related AD is different from classic FBN1-affected AD.
Relationship between common SNP and collagen or MMPs/TIMPs related AD pathogenesis
To investigate the common SNPs' contribution of collagen and MMPs/TIMPs related AD pathogenesis, we compared the minor allele frequency of all SNPs located in exons in the 72 genes between AD cases and controls. However, there is no significantly statistical difference, which implies that rare variants might be the key points of AD pathogenesis.
DISCUSSION
To our knowledge, this is a first comprehensive targeted resequencing study specifically for genetic alterations in genes of collagens and MMPs/TIMPs system in sporadic AD patients to date. We identified a series of LOF and likely pathogenic variants in selected new genes in 702 AD patients, indicating important new causes of the pathogenesis of this disease (Figure 1 and Tables 1 and S3 in Supporting Information). Besides, pedigrees co-segregation analysis and mRNA-expression analysis further support these genes are responsible for AD pathogenesis. Finally, we demonstrate that COL5A2 is a novel disease causing gene of sporadic AD by Col5a2 −/− knock-out rat models.
The COL5A1, COL5A2 and COL5A3 genes encode type V fibrillar collagen (Connizzo et al., 2015) . Pathogenic variants in these genes were previously deemed to cause EDS classic type (Connizzo et al., 2015; Ritelli et al., 2013) . Classic type EDS are rare autosomal dominant connective tissue disorders that are characterized by skin hyperextensibility, abnormal wound healing/atrophic scars, joint hypermobility and should exclude aortic defects (Ritelli et al., 2013) . However, our study provided evidences that these genes also take part in AD pathogenesis. Similarly, COL3A1, COL24A1 and COL2A1 are also fibrillar-coding collagens, and are widely and abundantly expressed in aorta walls (Theocharis et al., 2016) . Mutations of these genes and consequential structure of abnormal collagens will directly reduce the fastness of aorta.
Collagen type VI (COL6A6, COL6A5, COL6A3) are identified most LOF variants in our study, and the relationship with AD pathogenesis was supported by mRNA-analysis as well as pedigree co-segregation analysis. Previous study associated collagen type VI with Bethlem myopathy (Fitzgerald et al., 2013) . However, our LOF variants affected AD patients did not have related symptoms or family history after carefully physical examination and inquiry. Collagen type VI and type XXVIII (COL28A1) belongs to Beaded-filament-forming collagens, which interact with various ECM proteins, and they are thus important in ECM protein binding and co-localization (Theocharis et al., 2016) .
Collagen type XVIII (COL18A1) is a multiplexin, involving in production of endostatin which potently inhibits endothelial cell proliferation (Theocharis et al., 2016) . mRNAanalysis found that COL18A1 was enriched in healthy human aorta, and a splice variant in our AD patient resulted in nine times elevation in COL18A1 mRNA in aorta compared with the controls (Figure 5A and C) .
In addition, Collagen type VII (COL7A1) is an anchoring fibril; type X (COL10A1), VIII (COL8A1) and IV (COL4A3, COL4A4) are networking-forming collagens; type XII (COL12A1), XIV (COL14A1), XVI (COL16A1), XX (COL20A1), XXI (COL21A1) are FACITs (fibril-associated collagens with interrupted triple helices) (Theocharis et al., 2016) . They anchor or connect with various ECM elements, and provide aorta capable and flexible. The LOF variants in these genes may break the inner connection of ECM, thereupon interrupt the homeostasis of ECM. The MMPs/TIMPs have robust associations with AD in association studies (Song et al., 2013; Wang et al., 2014; Zhang et al., 2009) , indicating that functional variants within MMPs/TIMPs genes may lead to degrading of various components of the aortic ECM or result in aorta inflammation, therefore, playing an important role in AD pathogenesis (Theruvath et al., 2012) . However, none of the MMPs coding genes have been regarded as AD-causing gene in the past. Our data identified LOF (four frameshift deletion; five nonsense; three splice site) and likely pathogenic variants in MMPs in AD patients for the first time.
Although our study identify a series of LOF and like pathogenic variants in sporadic AD patients, missing heritability still remains, which indicates that targeted sequencing is not enough to find full spectrum of sporadic AD. More comprehensive strategies such as whole exome sequencing or whole genome sequencing should be considered in future studies.
In conclusion, this is a first study on targeted resequencing of the genes in all collagens and MMPs/TIMPs system in large scale AD patients to date, and provide a comprehensive map of genetic alternations in this system. We identified COL5A2 as novel sporadic AD pathogenic genes. We also highlight collagen type VI (COL6A6, COL6A5, COL6A3), COL18A1, and MMP19 genes in AD pathogenesis. Our data also indicate that next-generation targeted resequencing may be a powerful and effective method for the genetic diagnosis of AD, which can be used for risk stratification among patients' first-degree relatives.
MATERIALS AND METHODS
Study design and eligibility
In this study, we recruited two cohorts of Han Chinese descent, including 702 sporadic AD patients (cases) and 163 matched unrelated healthy volunteers (controls). Recruitment of the participants was conducted at the Tongji Hospital. The cases were selected from patients with AD as defined by computed tomography (CT) or magnetic resonance imaging. The controls were randomly recruited from healthy individuals undergoing routine health examinations. All controls were determined to be free of AD by medical history inquiry and definitive imaging examinations including ultrasonography and CT. All enrolled participants underwent a review of medical history, physical examinations, several laboratory assessments of AD risk factors and a consultation to determine their ethnic origin.
This study was approved by the Institutional Review Board of Tongji Hospital. Written informed consent was obtained from all participants. All the experiments were conducted according to the principles expressed in the Declaration of Helsinki.
Gene selection
To systemically study genetic defects of genes in collagens and MMPs/TIMPs system in pathogenic process in AD, we collected all thus far known human genes coding collagens and MMPs/TIMPs for resequencing, including 45 collagen coding genes, 23 MMPs coding genes and four TIMPs coding genes (Table S3 in Supporting Information).
Targeted semiconductor sequencing
Genomic DNA was extracted from blood samples of all participants and was diluted to 5 ng μL −1
. We performed nextgeneration semiconductor sequencing using the Ion torrent platform. Briefly, adapter-ligated libraries were constructed using the Ion AmpliSeq TM Library Kit 2.0 and custom-ordered multiplex PCR primer pools (Life Technologies, USA) following the manufacturer's protocol. After purification, libraries were quantitated using a Qubit 2.0 fluorometer (Invitrogen, USA) and were combined at equal molar ratios for sequencing as previously described (Li et al., 2014) .
Bioinformatic analysis
The next-generation sequencing data were initially processed using the Ion Torrent platform-specific software Torrent Suite v5.0. The sequences were aligned to the hg19/GRCh37 human reference genome to analyze the coverage and call variants. Then, all variants were annotated using Ion reporter 5.0. We removed common variants in the 1000-Genomes-Project database, the UCSC common SNP database, the Exome Aggregation Consortium (ExAC) database, and the Exome Sequencing Project (ESP). To predict the possible impact of detected non-synonymous variants in the exons on the encoded proteins, all the missense substitutions were scored and predicted using SIFT and PolyPhen-2. The degrees of conservation across multiple species of the non-synonymous variants were estimated by the Grantham and phyloP scores.
Criteria for pathogenic and likely pathogenic variants
We divided the AD-associated variants into "pathogenic" and "likely pathogenic" according to the guideline (Richards et al., 2015) . The following criteria were used to determine that a variant was pathogenic: it should be validated by Sanger sequencing; and it should have been reported as causal variants in the NCBI ClinVar database or HGMD database.
The following criteria were used to determine that a variant was likely pathogenic: it should be found in one or more cases and be absent in all healthy controls; it should be validated by Sanger sequencing; it should not be found as common SNP in the 1000-Genomes-Project database, the UCSC common SNP database, the ExAC database, and the ESP; it should be an exonic non-synonymous variant or canonical±2 splice sites; if it is a missense substitution, it should be predicted conservative by Grantham or phyloP score; and both of the SIFT and Polyphen-2 bioinformatic predictions should be damaging.
Sanger sequencing validation
PCR amplification was optimized in accordance with the manual for Taq™ Hot Start version (TaKaRa, Japan). To exclude any possible false-positive errors, Sanger sequencing was performed for all pathogenic or likely pathogenic variants using the Big Dye v.1.1 terminator cycle sequencing kit and an Applied Biosystems 3500xl capillary sequencer (Applied Biosystems, CA). The technically uncovered 3,972 bp regions of the 72 selected genes were sequenced directly by Sanger sequencing.
Statistical analysis
Fisher exact test was used to assess the difference in variant frequencies between cases and controls. The statistical analysis was performed with the use of SPSS software, version 20.0 (SPSS). A two-sided P value of less than 0.05 was considered to indicate statistical significance.
Gene expression analysis
We performed transcriptome sequencing and real-time PCR to evaluate the tissue expression of some identified novel genes that may be responsible for AD pathogenesis in aorta tissue from seven AD patients who underwent aortic surgery. Total RNA was extracted from frozen human aorta tissue using a TRIzol Reagent (Invitrogen). For real-time PCR, total RNA was reverse-transcribed to cDNA using M-MLV First Strand Kit (Invitrogen), and amplified using Power SYBR Green PCR Master Mix (Invitrogen) on Step One Plus real time PCR system (Applied Biosystems). We performed comprehensive RNA sequencing of aorta samples of AD patients, as well as healthy controls using Ion AmpliSeq™ Transcriptome Human Gene Expression Research Panel (Life Technologies) following the manufacturer's protocol (https://ioncommunity.thermofisher.com/docs/DOC-8980), and analysis the data by using Ion reporter 5.0.
Preparation of Col5a2 knockout rats
SD rats were bred in standard cages in an Assessment and Accreditation of Laboratory Animal Care-accredited SPF animal facility. All animal protocols were approved by the Animal Care and Use Committees of the Institute of Laboratory Animal Science of Chinese Academy of Medical Sciences (ILAS-GC-2015-002).
The paired synthesized oligonucleotides for sgRNAs were annealed and cloned into the pUSD-sgRNA expression vector (#51132, Addgene, USA) before in vitro transcription and microinjection. The Cas9 expression plasmid (#44758, Addgene) was linearized with Age I and used as the template for in vitro transcription using the T7 Ultra Kit (AM1345, Ambion, USA). sgRNA expression plasmids were linearized with Dra I and used as templates for in vitro transcription using the MEGAshortscript Kit (AM1354, Ambion). Transcribed Cas9 mRNA and sgRNA were both purified by using the MEGAclear Kit (AM1908, Ambion). SD rats were purchased from Beijing Vital River Laboratories animal center are housed in standard cages and maintained on a 12-h light/dark cycle with food and water. The microinjection of fertilized rat eggs was performed in Zhang's lab, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences. New pups genomic DNA was extracted from the tails of 7-day-old rats for sequencing. Rats with wanted mutations were prepared for consequence experiment. Figure S1 Normalized expression level of top 15 genes.
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Figure S2
The mRNA differentially expression level of 12 novel identified LOF or likely pathogenic variants in AD cases.
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